3 results
Approved WMOCompleted
The purpose of this current study is to evaluate the efficacy and safety of the 3-day oral aprepitant regimen when administered concomitantly with ondansetron, with or without dexamethasone, in pediatric patients, from 6 months to 17 years of age,…
Approved WMOCompleted
The objective of the present study is to characterize the dose-response relationship of PURETHAL® Mites (PM) with a nasal provocation test in order to identify the optimal dose in terms of highest clinical efficacy and safety.
Approved WMOCompleted
To investigate the influence of aprepitant on the exposure to etoposide in TC patients treated with (B)EP.